B
Barinthus Biotherapeutics plc (BRNS)
NGM – Real vaqt narxi. Valyuta: USD
0.70
+0.01 (2.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.70
+0.01 (2.19%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Barinthus Biotherapeutics plc o'z sho'ba korxonalari bilan birgalikda Qo'shma Shtatlar va Buyuk Britaniyada immunoterapiya va vaktsinalarni tadqiq qilish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya VTP-1000ni ishlab chiqadi, bu antigenga xos immun tolerantlik nomzodi bo'lib, u Seliakiya bilan og'rigan bemorlarda glyutenga immunitetning javob bermasligini tiklash uchun I bosqich klinik sinovidan o'tmoqda; va VTP-300, bu surunkali gepatit B virusli infektsiyasini davolash uchun II bosqich klinik sinovida bo'lgan immunoterapiya. Kompaniya termo-reaktiv adjuvant scaffoldlarga ega mahsulotlarni ishlab chiqish va tijoratlashtirish uchun Oxford University Innovation bilan; va AQSh Milliy Sog'liqni Saqlash Institutlari bilan hayvonlar modellarida yuqumli kasalliklarning oldini olish va saratonni davolash uchun sintetik va polimer asosidagi vaktsina texnologiyasini baholash bo'yicha litsenzion kelishuvga ega. Kompaniya ilgari Vaccitech plc nomi bilan tanilgan va 2023 yil noyabr oyida Barinthus Biotherapeutics plc nomiga o'zgargan. Barinthus Biotherapeutics plc 2016-yilda tashkil etilgan va Germantown, Merilendda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Leon Hooftman M.D. | Chief Medical Officer |
| Mr. William James Enright MBA | CEO, Director, Secretary & Principal Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 10-Q | brns-20260331.htm |
| 2026-04-22 | 8-K | tm2612491d1_8k.htm |
| 2026-04-13 | S-4/A | tm2530015-14_s4a.htm |
| 2026-03-31 | 8-K | tm2610673d1_8k.htm |
| 2026-03-13 | 8-K | brns-20260313.htm |
| 2026-02-23 | 8-K | tm266347d1_8k.htm |
| 2026-02-23 | 425 | tm266347d2_425.htm |
| 2026-01-27 | S-4/A | tm2530015-3_s4a.htm |
| 2026-01-06 | 8-K | brns-20251230.htm |
| 2025-12-10 | 8-K | brns-20251210.htm |